andrew kaczynski @KFILE
The seller of brain-cancer drug Gleostine pulled out of a federal discount program for Medicare, leaving patients struggling to pay for a therapy that can cost up to $1,000 per pill. They previously raised the drug’s price exponentially since acquiring it. https://t.co/QKxD1J69xZ — PolitiTweet.org
